Fulcrum Therapeutics(FULC)
搜索文档
Fulcrum Therapeutics (FULC) Investor Presentation - Slideshow
2021-05-15 02:23
Fulcrum | --- | --- | --- | --- | |-------------------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | Regulating Gene Expression to Treat the Root Cause of Disease May 2021 | | | | | | | | | Disclaimer and Notice This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties, including statements regarding the development status of the Com ...
Fulcrum Therapeutics(FULC) - 2021 Q1 - Earnings Call Transcript
2021-05-09 03:19
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2021 Earnings Conference Call May 6, 2021 8:00 AM ET Company Participants Christi Waarich - Director, Investor Relations & Corporate Communications Bryan Stuart - President & Chief Executive Officer Chris Moxham - Chief Scientific Officer Peter Thomson - Vice President, Finance & Accounting Conference Call Participants Kelly Girskis - SVB Leerink Ted Tenthoff - Piper Sandler Kostas Biliouris - Morgan Stanley Tazeen Ahmad - Bank of America Operator Good morning, an ...
Fulcrum Therapeutics (FULC) Investor Presentation - Slideshow
2021-03-20 03:03
Fulcrum | --- | --- | --- | --- | --- | |---------------------------------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | Regulating Gene Expression to Treat the Root Cause of Disease March 2021 | | | | | | | | | | | Disclaimer and Notice This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties, including statements regarding the dev ...
Fulcrum Therapeutics(FULC) - 2020 Q4 - Earnings Call Transcript
2021-03-05 02:43
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2020 Results Earnings Conference Call March 4, 2021 8:00 AM ET Â Company Participants Christi Waarich - Director, Investor Relations and Corporate Communications Robert Gould - President & CEO Bryan Stuart - Chief Operating Officer Chris Moxham - Chief Scientific Officer Peter Thomson - Vice President, Finance and Accounting Conference Call Participants Ted Tenthoff - Piper Sandler Joseph Schwartz - SVB Leerink Dae Gon Ha - Stifel Matthew Harrison - Morgan Stanley ...
Fulcrum Therapeutics(FULC) - 2020 Q3 - Earnings Call Transcript
2020-11-11 01:45
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2020 Earnings Conference Call November 9, 2020 8:00 AM ET Company Participants Robert Gould - CEO, President & Director Diego Cadavid - SVP of Clinical Development Owen Wallace - Chief Scientific Officer Bryan Stuart - Chief Operating Officer Christi Waarich - Director, Corporate Communications & IR Conference Call Participants Ted Tenthoff - Piper Sandler Joseph Schwartz - SVB Leerink Kostas Biliouris - Morgan Stanley Operator Good morning, and welcome to the Ful ...
Fulcrum Therapeutics (FULC) Investor Presentation - Slideshow
2020-09-19 01:53
Fulcrum | --- | --- | --- | --- | |-------------------------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | Regulating Gene Expression to Treat the Root Cause of Disease September 2020 | | | | | | | | | Disclaimer and Notice This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties, including statements regarding the development statu ...
Fulcrum Therapeutics(FULC) - 2020 Q2 - Earnings Call Presentation
2020-08-14 05:14
Fulcrum | --- | --- | --- | --- | --- | --- | |---------------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fulcrum Q2 2020 Conference Call | | | | | | | August 11, 2020 | | | | | | | | | | | | | | | | | | | | Disclaimer and Notice This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties, including statements regard ...
Fulcrum Therapeutics(FULC) - 2020 Q2 - Earnings Call Transcript
2020-08-12 12:02
Fulcrum Therapeutics Inc. (NASDAQ:FULC) Q2 2020 Results Conference Call August 11, 2020 8:00 AM ET Company Participants Christi Waarich - Director, Corporate Communications & IR Robert Gould - CEO, President & Director Diego Cadavid - SVP of Clinical Development Owen Wallace - Chief Scientific Officer Bryan Stuart - Chief Operating Officer Conference Call Participants Joseph Schwartz - SVB Leerink Dae Gon Ha - BTIG Tazeen Ahmad - Bank of America Ted Tenthoff - Piper Sandler Matthew Harrison - Morgan Stanley ...
Fulcrum Therapeutics(FULC) - 2020 Q1 - Earnings Call Transcript
2020-05-14 01:15
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2020 Earnings Conference Call May 13, 2020 8:00 AM ET Company Participants Christi Waarich - Director of Investor Relations and Corporate Communications Robert Gould - President and Chief Executive Officer Owen Wallace - Chief Scientific Officer Bryan Stuart - Chief Operating Officer Diego Cadavid - Senior Vice President of Clinical Development Conference Call Participants Joseph Schwartz - SVB Leerink Tazeen Ahmad - Bank of America Operator Good morning and welco ...
Fulcrum Therapeutics(FULC) - 2019 Q4 - Earnings Call Transcript
2020-03-06 03:21
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2019 Earnings Conference Call March 5, 2020 8:00 AM ET Company Participants Christi Waarich - Director of Investor Relations and Corporate Communications Robert Gould - President and Chief Executive Officer Owen Wallace - Chief Scientific Officer Bryan Stuart - Chief Operating Officer Diego Cadavid - Senior Vice President of Clinical Development Conference Call Participants Matthew Harrison - Morgan Stanley Joseph Schwartz - SVB Leerink Tazeen Ahmad - Bank of Amer ...